In separate, live events, Binod Dhakal, MD, MS; and Laahn H. Foster, MD, polled oncologists on therapeutic options for a ...
Doctors at AIIMS, Delhi are in the process of developing a low cost antibody-based adaptive cellular therapy for the ...
In April 2024, the TAG-CO-VAC recommended the use of a monovalent JN.1 lineage vaccine antigen as one approach to induce enhanced neutralizing antibody responses to JN.1 and its descendent lineages.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback